Home » Clinical Trials » Search Clinical Trials
Therapeutic Areas: Nephrology | Infections and Infectious Diseases | Family Medicine
Clinical Trials: Interstitial Cystitis
A listing of clinical trials currently looking for volunteers to enroll in Interstitial Cystitis studies. Click on the closest city to find more detailed information on a research study in your area.
Alabama
Birmingham : MediciNova Investigational Site
Phase II Study to Evaluate the Efficacy and Safety of Two Dosing Regimens of MN-001 in Patients With Interstitial Cystitis
California
Escondido : Philip C. Bosch, MD
Efficacy Study of Adalimumab to Treat Interstitial Cystitis
Glendora : MediciNova Investigational Site
Phase II Study to Evaluate the Efficacy and Safety of Two Dosing Regimens of MN-001 in Patients With Interstitial Cystitis
Long Beach : MediciNova Investigational Site
Phase II Study to Evaluate the Efficacy and Safety of Two Dosing Regimens of MN-001 in Patients With Interstitial Cystitis
San Diego : MediciNova Investigational Site
Phase II Study to Evaluate the Efficacy and Safety of Two Dosing Regimens of MN-001 in Patients With Interstitial Cystitis
Colorado
Boulder : MediciNova Investigational Site
Phase II Study to Evaluate the Efficacy and Safety of Two Dosing Regimens of MN-001 in Patients With Interstitial Cystitis
Wheat Ridge : MediciNova Investigational Site
Phase II Study to Evaluate the Efficacy and Safety of Two Dosing Regimens of MN-001 in Patients With Interstitial Cystitis
Florida
Aventura : MediciNova Investigational Site
Phase II Study to Evaluate the Efficacy and Safety of Two Dosing Regimens of MN-001 in Patients With Interstitial Cystitis
Boynton Beach : MediciNova Investigational Site
Phase II Study to Evaluate the Efficacy and Safety of Two Dosing Regimens of MN-001 in Patients With Interstitial Cystitis
Palm Harbor : MediciNova Investigational Site
Phase II Study to Evaluate the Efficacy and Safety of Two Dosing Regimens of MN-001 in Patients With Interstitial Cystitis
Plantation : MediciNova Investigational Site
Phase II Study to Evaluate the Efficacy and Safety of Two Dosing Regimens of MN-001 in Patients With Interstitial Cystitis
Wellington : MediciNova Investigational Site
Phase II Study to Evaluate the Efficacy and Safety of Two Dosing Regimens of MN-001 in Patients With Interstitial Cystitis
Georgia
Atlanta : MediciNova Investigational Site
Phase II Study to Evaluate the Efficacy and Safety of Two Dosing Regimens of MN-001 in Patients With Interstitial Cystitis
Illinois
Centralia : MediciNova Investigational Site
Phase II Study to Evaluate the Efficacy and Safety of Two Dosing Regimens of MN-001 in Patients With Interstitial Cystitis
Evanston : MediciNova Investigational Site
Phase II Study to Evaluate the Efficacy and Safety of Two Dosing Regimens of MN-001 in Patients With Interstitial Cystitis
Louisiana
Shreveport : MediciNova Investigational Site
Phase II Study to Evaluate the Efficacy and Safety of Two Dosing Regimens of MN-001 in Patients With Interstitial Cystitis
Michigan
Royal Oak : MediciNova Investigational Site
Phase II Study to Evaluate the Efficacy and Safety of Two Dosing Regimens of MN-001 in Patients With Interstitial Cystitis
Nevada
Las Vegas : MediciNova Investigational Site
Phase II Study to Evaluate the Efficacy and Safety of Two Dosing Regimens of MN-001 in Patients With Interstitial Cystitis
New Jersey
Marlton : MediciNova Investigational Site
Phase II Study to Evaluate the Efficacy and Safety of Two Dosing Regimens of MN-001 in Patients With Interstitial Cystitis
New York
Albany : MediciNova Investigational Site
Phase II Study to Evaluate the Efficacy and Safety of Two Dosing Regimens of MN-001 in Patients With Interstitial Cystitis
North Carolina
Raleigh : Wake Research Associates
Study of Moderate to Severe Bladder Pain (Interstitial Cystitis)
Winston-Salem : PMG Research of Winston-Salem
Attention Females! Do you live with pelvic pain, pressure, discomfort, and frequent urination?
View More »
Winston Salem : MediciNova Investigational Site
Phase II Study to Evaluate the Efficacy and Safety of Two Dosing Regimens of MN-001 in Patients With Interstitial Cystitis
Ohio
Cincinnati : MediciNova Investigational Site
Phase II Study to Evaluate the Efficacy and Safety of Two Dosing Regimens of MN-001 in Patients With Interstitial Cystitis
Lima : MediciNova Investigational Site
Phase II Study to Evaluate the Efficacy and Safety of Two Dosing Regimens of MN-001 in Patients With Interstitial Cystitis
Oregon
Tualatin : MediciNova Investigational Site
Phase II Study to Evaluate the Efficacy and Safety of Two Dosing Regimens of MN-001 in Patients With Interstitial Cystitis
Pennsylvania
South Carolina
Greer : MediciNova Investigational Site
Phase II Study to Evaluate the Efficacy and Safety of Two Dosing Regimens of MN-001 in Patients With Interstitial Cystitis
Texas
Corsicana : MediciNova Investigational Site
Phase II Study to Evaluate the Efficacy and Safety of Two Dosing Regimens of MN-001 in Patients With Interstitial Cystitis
Fort Worth : MediciNova Investigational Site
Phase II Study to Evaluate the Efficacy and Safety of Two Dosing Regimens of MN-001 in Patients With Interstitial Cystitis
Utah
Ogden : MediciNova Investigational Site
Phase II Study to Evaluate the Efficacy and Safety of Two Dosing Regimens of MN-001 in Patients With Interstitial Cystitis
Washington
Mountlake Terrace : Integrity Medical Research, LLC
A Phase 2a Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study Evaluating Safety, Tolerability and Efficacy of LiRIS® in Women With Interstitial Cystitis Followed by an Open Label Extension
View More »
Mountlake Terrace : MediciNova Investigational Site
Phase II Study to Evaluate the Efficacy and Safety of Two Dosing Regimens of MN-001 in Patients With Interstitial Cystitis
Canada
Brampton : Bramalea Medical Centre
Safety Study of Single Intravesical Doses of TTI-1612 in Women With Interstitial Cystitis/Bladder Pain Syndrome
Kitchener : Urology Associates/Urologic Medical Research
Safety Study of Single Intravesical Doses of TTI-1612 in Women With Interstitial Cystitis/Bladder Pain Syndrome
Oakville : The Fe/Male Health Centres
Safety Study of Single Intravesical Doses of TTI-1612 in Women With Interstitial Cystitis/Bladder Pain Syndrome
Toronto : Urology & Male Fertility Clinic
Safety Study of Single Intravesical Doses of TTI-1612 in Women With Interstitial Cystitis/Bladder Pain Syndrome
Czech Republic
Prague :
OXN PR vs Placebo in Opioid-naive Subjects Suffering From Severe Pain Due to Bladder Pain Syndrome (BPS)
Poland
Krakow :
OXN PR vs Placebo in Opioid-naive Subjects Suffering From Severe Pain Due to Bladder Pain Syndrome (BPS)
United Kingdom
Sheffield : Royal Hallamshire Hospital
OXN PR vs Placebo in Opioid-naive Subjects Suffering From Severe Pain Due to Bladder Pain Syndrome (BPS)
